Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

Recent & Breaking News (OTCQX:MRVFF)

Nuvo Pharmaceuticals® Announces The Canadian Commercial Launch of Suvexx(TM) - For The Acute Treatment of Migraine

PR Newswire September 9, 2020

Nuvo Pharmaceuticals® Announces Second Quarter 2020 Results

Canada NewsWire August 10, 2020

Nuvo Pharmaceuticals(TM) Announces Second Quarter 2020 Results Release Date and Conference Call Details

Canada NewsWire July 27, 2020

Nuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of Shareholders

Canada NewsWire May 12, 2020

Nuvo Pharmaceuticals® Announces First Quarter 2020 Results

Canada NewsWire May 11, 2020

C-Suite At The Open: Jesse Ledger, Chief Executive Officer, Nuvo Pharmaceuticals Inc., tells his Company's Story. Filmed on April 24, 2020

Canada NewsWire April 30, 2020

Nuvo Pharmaceuticals® Announces First Quarter 2020 Results Release Date and Virtual Annual & Special Meeting of Shareholders

Canada NewsWire April 27, 2020

Nuvo Pharmaceuticals® Announces Approval of Takeda's Cabpirin Tablets in Japan, Triggering a US$2.0 Million Milestone Payment due in Q2 2020

Canada NewsWire March 31, 2020

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

GlobeNewswire March 30, 2020

Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020

GlobeNewswire March 24, 2020

Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum March 26th

GlobeNewswire March 23, 2020

Nuvo Pharmaceuticals® Announces "at risk" Launch of Generic Version of Vimovo in the United States

Canada NewsWire March 4, 2020

Nuvo Pharmaceuticals® Announces Health Canada Approves Suvexx(TM) For The Acute Treatment of Migraine

Canada NewsWire February 27, 2020

Nuvo Pharmaceuticals® Announces 2019 and Fourth Quarter Results

Canada NewsWire February 25, 2020

Nuvo Pharmaceuticals(TM) Responds to Market Activity

Canada NewsWire February 11, 2020

Nuvo Pharmaceuticals(TM) Announces Fourth Quarter 2019 Results Release Date and Conference Call Details

Canada NewsWire February 11, 2020

Nuvo Pharmaceuticals(TM) Announces Repayment of Bridge Loan and Entitlement to Receive 2019 Vimovo U.S. Annual Minimum Royalty

Canada NewsWire January 7, 2020

Nuvo Pharmaceuticals(TM) Announces United States District Court Denies Dr. Reddy's Laboratories Motion for Summary Judgment of Nuvo's '996 and '920 VIMOVO Patents

Canada NewsWire November 11, 2019

Nuvo Pharmaceuticals(TM) Announces 2019 Third Quarter Results

Canada NewsWire October 31, 2019

Nuvo Pharmaceuticals(TM) Announces Third Quarter 2019 Results Release Date and Conference Call Details

Canada NewsWire October 17, 2019